P9 Comparison of cetuximab and bevacizumab as first-line treatment in KRAS wild type advanced colorectal cancer patients: a retrospective analysis.

Saved in:
Bibliographic Details
Title: P9 Comparison of cetuximab and bevacizumab as first-line treatment in KRAS wild type advanced colorectal cancer patients: a retrospective analysis.
Authors: Zhang, Q., Leung, R., Wong, H., Chiu, J., Chu, K.W., Poon, J., Epstein, R.J., Kwong, Y.L., Yau, T.
Source: European Journal of Cancer. Mar2014 Supplement, Vol. 50, pS12-S12. 1p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/S0959-8049(14)70040-1